Antiatherogenic activity of FR34235 (Nilvadipine), a new potent calcium antagonist

This publication has 23 references indexed in Scilit:

• Inflammatory responses in cuff-induced atherosclerosis in rabbits
  Atherosclerosis, 1987
• Does nifedipine suppress atherogenesis in WHHL rabbits?
  Atherosclerosis, 1984
• No effect of nifedipine on atherogenesis in cholesterol-fed rabbits.
  Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1984
• Ineffectiveness of Ca2+-antagonists nicardipine and diltiazem on experimental atherosclerosis in cholesterol-fed rabbits
  Atherosclerosis, 1984
• Cardiovascular Effects of FR34235, a New Dihydropyridine Slow Channel Blocker, in Isolated Rabbit Myocardium and Aorta
  Journal of Cardiovascular Pharmacology, 1983
• The inhibitory action of FR 34235 (A new Ca2+ entry blocker) as compared to nimodipine and nifedipine on the contractile response to norepinephrine, potassium and 5-hydroxytryptamine in rabbit basilar artery
  European Journal of Pharmacology, 1983
• Calcium dependency of aortic smooth muscle cell migration induced by 12-l-hydroxy-5,8,10,14-eicosatetraenoic acid
  Atherosclerosis, 1983
• Comparative pharmacology of calcium antagonists: Nifedipine, verapamil and diltiazem
  The American Journal of Cardiology, 1980
• Control of DNA synthesis in cultured vascular endothelial and smooth muscle cells Response to serum, platelet-deficient serum, lipid-free serum, insulin and oestrogens
  Atherosclerosis, 1980
• Atherosclerosis and the Arterial Smooth Muscle Cell
  Science, 1973